Comments on: President Obama, Pharma And Pricing Pressures http://www.pharmalot.com/2008/11/president-obama-pharma-and-pricing-pressures/ News, Comment and Conversation Fri, 10 Feb 2012 22:28:03 +0000 http://wordpress.org/?v=2.6.2 By: Ross http://www.pharmalot.com/2008/11/president-obama-pharma-and-pricing-pressures/#comment-380566 Ross Thu, 06 Nov 2008 01:51:54 +0000 http://www.pharmalot.com/?p=17301#comment-380566 Over the next four years, the pharmaceutical industry is going to find itself between Barack and a hard place! Over the next four years, the pharmaceutical industry is going to find itself between Barack and a hard place!

]]> By: Bob Freeman http://www.pharmalot.com/2008/11/president-obama-pharma-and-pricing-pressures/#comment-380552 Bob Freeman Wed, 05 Nov 2008 23:32:02 +0000 http://www.pharmalot.com/?p=17301#comment-380552 Atlex, you may be right-it all comes down to where this falls on the priority list and whether "tinkering" can be done rather than reform. I would think at this point strenghtening the FDA and the health insurance coverage debate will take priority. Atlex, you may be right-it all comes down to where this falls on the priority list and whether “tinkering” can be done rather than reform.

I would think at this point strenghtening the FDA and the health insurance coverage debate will take priority.

]]> By: Sophie http://www.pharmalot.com/2008/11/president-obama-pharma-and-pricing-pressures/#comment-380549 Sophie Wed, 05 Nov 2008 21:59:07 +0000 http://www.pharmalot.com/?p=17301#comment-380549 Part D is a ripoff to the American taxpayer. Let's hope it comes to Obama's attention and he does something about the pricing. I permanently gave up my AARP membership when they backed the full-price bill. Part D is a ripoff to the American taxpayer. Let’s hope it comes to Obama’s attention and he does something about the pricing. I permanently gave up my AARP membership when they backed the full-price bill.

]]> By: atlex http://www.pharmalot.com/2008/11/president-obama-pharma-and-pricing-pressures/#comment-380529 atlex Wed, 05 Nov 2008 21:23:50 +0000 http://www.pharmalot.com/?p=17301#comment-380529 Bob, I disagree with Zhang regarding Part D. There are a number of proposed measures that could be easily (relatively speaking) implemented without destroying the current structure of this popular program. Waxman and Baucus have two very different approaches, both of which can be implemented without significant changes. And, since Congress is going to have a great desire to eliminate the "overpayment" to MA plans, it would be easy to use that legislation to make changes to Part D. Atlex Bob,

I disagree with Zhang regarding Part D. There are a number of proposed measures that could be easily (relatively speaking) implemented without destroying the current structure of this popular program. Waxman and Baucus have two very different approaches, both of which can be implemented without significant changes. And, since Congress is going to have a great desire to eliminate the “overpayment” to MA plans, it would be easy to use that legislation to make changes to Part D.

Atlex

]]> By: Bob Freeman http://www.pharmalot.com/2008/11/president-obama-pharma-and-pricing-pressures/#comment-380525 Bob Freeman Wed, 05 Nov 2008 20:10:49 +0000 http://www.pharmalot.com/?p=17301#comment-380525 Agree with Zhang--doubtful that the Medicare Part D law would be reopened just to deal with the pricing issue. If the benefit were to be reformed strucutally then the effort would be justified. It would be much easier for CMS to write regs lowering reimbursment to PDPs and Medicare Advantage plans than it would be to reopen the entire law. Agree with Zhang–doubtful that the Medicare Part D law would be reopened just to deal with the pricing issue. If the benefit were to be reformed strucutally then the effort would be justified.

It would be much easier for CMS to write regs lowering reimbursment to PDPs and Medicare Advantage plans than it would be to reopen the entire law.

]]> By: Jane Sarasohn-Kahn http://www.pharmalot.com/2008/11/president-obama-pharma-and-pricing-pressures/#comment-380507 Jane Sarasohn-Kahn Wed, 05 Nov 2008 16:06:08 +0000 http://www.pharmalot.com/?p=17301#comment-380507 Health care's microeconomy is part of the larger US health macroeconomy. If someone like Peter Orszag, from the current Congressional Budget Office, is brought into head up, say, CMS, then health policy will play an integral role in the nation's macro-economic planning. He's been talking a lot about cost-drivers in the health economy over the past 2 years, and is named as a possible Obama appointee for CMS director. Health care’s microeconomy is part of the larger US health macroeconomy. If someone like Peter Orszag, from the current Congressional Budget Office, is brought into head up, say, CMS, then health policy will play an integral role in the nation’s macro-economic planning. He’s been talking a lot about cost-drivers in the health economy over the past 2 years, and is named as a possible Obama appointee for CMS director.

]]> By: Anne http://www.pharmalot.com/2008/11/president-obama-pharma-and-pricing-pressures/#comment-380502 Anne Wed, 05 Nov 2008 15:20:50 +0000 http://www.pharmalot.com/?p=17301#comment-380502 http://www.pharmalot.com/2008/04/pharma-still-betting-on-barack-obama/ http://www.pharmalot.com/2008/04/pharma-still-betting-on-barack-obama/

]]>